SCAM13020U Companion Animal Oncology - Medical Oncology II
The purpose of this course is to provide experience and expertise in the medical and multimodality management of companion animal cancer patients including indications for, planning of and administration of single and multiagent chemotherapy for the most commonly treated companion animal cancers and the principles and role of radiotherapy. The mechanism of action, principles of use of cytostatic drugs as well as the administration as either single agent or multi agent protocols or as part of multimodality approaches in the treatment of the most common companion animal cancers will be part of this module.
Furthermore classification, monitoring and prevention and management of chemotherapy adverse effects according to the guidelines established by VCOG (Veterinary Comparative Oncology Group).
Each participant makes procedures for the treatment protocols used to treat the most common companion animal medical oncology patients for their own practice.Having completed the course, the student must be able to:
Knowledge
• Describe and reflect about common ethical, safety, and
environmental considerations in treatment with cytostatic drugs in
companion animal cancer patients
• Define, identify and demonstrate overview of commonly used
companion animal cancer chemotherapy protocols and multimodality
approaches to therapeutic management
• List, classify, and demonstrate critical reflection on
existing and new medical or combined approaches to oncology patient
therapy and client education
• Demonstrate appropriate understanding regarding nutrition,
nutraceuticals and supplementary therapies in veterinary cancer
patients
• Be current on specific blood product transfusion-guidelines
and demonstrate an understanding of hemostatic disorders in
veterinary cancer patients.
• Have an in depth knowledge of cancer related pain
• Understand the use of radiotherapy in veterinary cancer
patients
Skills
• Use appropriate procedures and administration protocols for
medical management and follow up of specific companion animal
cancer types
• Interpret, assess and reflect on stage and grade of cancer
in relation to planning of the therapeutic approach incl. which
modalities, protocol and the administration of chemotherapy in
individual patients
• Plan, apply and integrate new evidence based scientific
approaches to plan and administer medical therapy in companion
animal cancer patients, pain management, nutritional management and
other supportive therapy
• Detect, assess and address adverse effects to cancer
chemotherapy effectively and in a timely fashion
• Communicate effectively in writing and pass on therapeutic
results to relevant parties
Competences
• Evaluate and manage the medical therapy of companion animal
cancer patients which may necessitate novel solutions and
approaches identified from current medical literature or other
ressources as they pertain to the individual patient
• Work independently, take responsibility for, predict, and
prognosticate based on response to therapy for commonly medically
treated companion animal cancers
• Collaborate constructively within and between
specialists/professionals and lay persons involved in companion
animal medical cancer treatment
• Independently evaluate and structure own learning processes
and continously obtain new knowledge within the medical management
of companion animal cancer patients
SCAM13001U, SCAM13002U, SCAM13003U, SCAM13004U, SCAM13019U or
Recertified Danish "Fagdyrlæge i sygdomme hos hund og kat" and SCAM13019U
- Category
- Hours
- Exam
- 50
- Lectures
- 10
- Preparation
- 72
- Theory exercises
- 30
- Total
- 162
- Credit
- 6 ECTS
- Type of assessment
- Written assignmentOral examinationAs a part of the course the student will have to perform oral presentations, hand in a number of in written exercises/cases and procedure protocols and a final webbased written report and present this at an oral examination.
- Exam registration requirements
- 80 % active participation in the on site course activities are required in order to obtain approved course certificate. Both, approved course certificate and a passed examination are required to pass the course. Students may attend examination without approval of course certificate.
- Aid
- All aids allowed
- Marking scale
- 7-point grading scale
- Censorship form
- External censorship
Criteria for exam assesment
Having completed the course, the student must be able to:
Knowledge
• Describe and reflect about common ethical, safety, and
environmental considerations in treatment with cytostatic drugs in
companion animal cancer patients
• Define, identify and demonstrate overview of commonly used
companion animal cancer chemotherapy protocols and multimodality
approaches to therapeutic management
• List, classify, and demonstrate critical reflection on
existing and new medical or combined approaches to oncology patient
therapy and client education
• Demonstrate appropriate understanding regarding nutrition,
nutraceuticals and supplementary therapies in veterinary cancer
patients
• Be current on specific blood product transfusion-guidelines
and demonstrate an understanding of hemostatic disorders in
veterinary cancer patients.
• Have an in depth knowledge of cancer related pain
• Understand the use of radiotherapy in veterinary cancer
patients
Skills
• Use appropriate procedures and administration protocols for
medical management and follow up of specific companion animal
cancer types
• Interpret, assess and reflect on stage and grade of cancer
in relation to planning of the therapeutic approach incl. which
modalities, protocol and the administration of chemotherapy in
individual patients
• Plan, apply and integrate new evidence based scientific
approaches to plan and administer medical therapy in companion
animal cancer patients, pain management, nutritional management and
other supportive therapy
• Detect, assess and address adverse effects to cancer
chemotherapy effectively and in a timely fashion
• Communicate effectively in writing and pass on therapeutic
results to relevant parties
Competences
• Evaluate and manage the medical therapy of companion animal
cancer patients which may necessitate novel solutions and
approaches identified from current medical literature or other
ressources as they pertain to the individual patient
• Work independently, take responsibility for, predict, and
prognosticate based on response to therapy for commonly medically
treated companion animal cancers
• Collaborate constructively within and between
specialists/professionals and lay persons involved in companion
animal medical cancer treatment
• Independently evaluate and structure own learning processes
and continously obtain new knowledge within the medical management
of companion animal cancer patients
Course information
- Language
- English
- Course code
- SCAM13020U
- Credit
- 6 ECTS
- Level
- Part Time Master
- Duration
- Practical 5-days course at University Hospital for Companion Animals (Universitetshospitalet for Familiedyr.)
- Placement
- Spring
- Schedule
- 11-15 April 2016
Monday - Friday full time - Course capacity
- 12
- Continuing and further education
- Price
- 31.500 DKK
- Study board
- Study Board of Veterinary Sciences
Contracting department
- Department of Veterinary Clinical and Animal Sciences
Course responsibles
- Annemarie Thuri Kristensen (atk@sund.ku.dk)